Next Article in Journal
Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?
Previous Article in Journal
PARylation During Transcription: Insights into the Fine-Tuning Mechanism and Regulation
Previous Article in Special Issue
Nanoparticles Loaded with the BET Inhibitor JQ1 Block the Growth of Triple Negative Breast Cancer Cells In Vitro and In Vivo
Open AccessReview

Vimentin Intermediate Filaments as Potential Target for Cancer Treatment

1
Department of Cell Biology, Charles University, Viničná 7, 12843 Prague, Czech Republic
2
Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 25242 Vestec u Prahy, Czech Republic
3
Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, 14220 Prague, Czech Republic
*
Authors to whom correspondence should be addressed.
These authors contributed equally.
Cancers 2020, 12(1), 184; https://doi.org/10.3390/cancers12010184
Received: 18 December 2019 / Revised: 8 January 2020 / Accepted: 9 January 2020 / Published: 11 January 2020
(This article belongs to the Special Issue Targeting Solid Tumors)
Intermediate filaments constitute the third component of the cellular skeleton. Unlike actin and microtubule cytoskeletons, the intermediate filaments are composed of a wide variety of structurally related proteins showing distinct expression patterns in tissues and cell types. Changes in the expression patterns of intermediate filaments are often associated with cancer progression; in particular with phenotypes leading to increased cellular migration and invasion. In this review we will describe the role of vimentin intermediate filaments in cancer cell migration, cell adhesion structures, and metastasis formation. The potential for targeting vimentin in cancer treatment and the development of drugs targeting vimentin will be reviewed. View Full-Text
Keywords: vimentin; EMT; invasion; mechanotransduction; cell adhesion; cancer treatment; cancer drugs; amoeboid; mesenchymal vimentin; EMT; invasion; mechanotransduction; cell adhesion; cancer treatment; cancer drugs; amoeboid; mesenchymal
Show Figures

Figure 1

MDPI and ACS Style

Strouhalova, K.; Přechová, M.; Gandalovičová, A.; Brábek, J.; Gregor, M.; Rosel, D. Vimentin Intermediate Filaments as Potential Target for Cancer Treatment. Cancers 2020, 12, 184.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop